[Erythropoietin--use in hematologic oncology and radiotherapy].
Zahner
J
J
Medizin & Forschung, Janssen-Cilag GmbH, Neuss.
D000740:Anemia / Q000097:blood / Q000628:therapy; D015687:Cell Hypoxia / Q000187:drug effects; D004921:Erythropoietin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000097:blood / Q000628:therapy*; D006801:Humans; D011379:Prognosis; D011878:Radiotherapy; D011994:Recombinant Proteins; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin